Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Pfizer Inc (PFE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Pfizer historical data, for real-time data please try another search
31.20 -0.10    -0.32%
05/10 - Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US7170811035 
S/N:  852009
  • Volume: 35
  • Bid/Ask: 31.20 / 31.40
  • Day's Range: 31.20 - 31.20
Pfizer 31.20 -0.10 -0.32%

PFE Balance Sheet

 
Featured here, the Balance Sheet for Pfizer Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2015
29/06
2015
29/03
2014
31/12
2014
28/09
Total Current Assets - 49443 57702 56987
Cash and Short Term Investments - 27708 36122 33446
Cash - - - -
Cash & Equivalents - 3563 3343 2437
Short Term Investments - 24145 32779 31009
Total Receivables, Net - 8920 8669 9955
Accounts Receivables - Trade, Net - 8920 8669 9955
Total Inventory - 5786 5663 6355
Prepaid Expenses - - - -
Other Current Assets, Total - 7029 7248 7231
Total Assets - 160640 169274 171362
Property/Plant/Equipment, Total - Net - 11527 11762 12032
Property/Plant/Equipment, Total - Gross - - - -
Accumulated Depreciation, Total - - - -
Goodwill, Net - 41854 42069 42724
Intangibles, Net - 34334 35166 36374
Long Term Investments - 18289 17518 18451
Note Receivable - Long Term - - - -
Other Long Term Assets, Total - 5193 5057 4794
Other Assets, Total - - - -
Total Current Liabilities - 20222 21631 19920
Accounts Payable - 2724 3440 2973
Payable/Accrued - - - -
Accrued Expenses - 1679 1784 1841
Notes Payable/Short Term Debt - - 2130 -
Current Port. of LT Debt/Capital Leases - 6555 3011 5389
Other Current liabilities, Total - 9264 11266 9717
Total Liabilities - 93336 97973 93374
Total Long Term Debt - 29370 31541 31666
Long Term Debt - 29370 31541 31666
Capital Lease Obligations - - - -
Deferred Income Tax - 24474 24981 26320
Minority Interest - 283 321 317
Other Liabilities, Total - 18987 19499 15151
Total Equity - 67304 71301 77988
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - 28 29 30
Common Stock, Total - 458 455 455
Additional Paid-In Capital - 80004 78977 78498
Retained Earnings (Accumulated Deficit) - 74471 72176 74292
Treasury Stock - Common - -79100 -73021 -71820
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - -271 -222 -78
Other Equity, Total - -8286 -7093 -3389
Total Liabilities & Shareholders' Equity - 160640 169274 171362
Total Common Shares Outstanding - 6157.67 6291 6300.66
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PFE Comments

Write your thoughts about Pfizer Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email